Global Next Generation Cancer Diagnostics Market Overview, Growth, Economics, Demand 2025

1. Next Generation Cancer Diagnostics Market 2025, Business Opportunity, Global Trend, Future Growth, Segmentation, Future Demands, Latest Innovation, Sales Next Generation Cancer Diagnostics Market Report provides in-depth analysis of industry by production, share, size, Demand, Proposition, Development, Opportunities, Growth, Economic Trends, Technologies Research, Segmentation, Key Futuristic, Investment Feasibility, Major Key Players, SWOT analysis and Forecast. Global Next Generation Cancer Diagnostics Market size was worth USD 4,964.05 million in 2016 which is anticipated to grow at a CAGR of more than 9.7% over the forecast period. Rise in mortality rate due to the increasing occurrence of the cancer, second most predominant disease accounting for approximately 8.8 million deaths in 2015 is anticipated to escalate the market for these tests. Advancements in tests enable early diagnosis and assist efficient detection of different types of tumors which in turn is expected to promote growth over the projected period. The introduction of new products by large bodies, merger, and acquisitions, and joint agreements such as the development of RNA-Seq Kit version by Agilent Technologies Inc. and Agendia Inc. are the factors accountable for the estimated CAGR. Browse Full Research Report @ https://www.millioninsights.com/industry-reports/next-generation-cancer-diagnostics-market An escalation in the development of companion diagnostics in order to deliver advanced and personalized genomic medicine is also responsible for progress in the coming years. Furthermore, the technological advancements driving the innovation in point-of-care testing devices is anticipated to aid in commercialization of advanced products thereby supporting revenue generation.

2. Technology Insights Incorporation of technological advancements such as melting curve examination for identification of mutations, qPCR tools for profiling of tumor in clinical test centers, and gene deletions are accountable for the largest share apprehended by multiplexing and qPCR segment. With the development of next-generation sequencing technology, the use of traditional methods such as protein and DNA microarrays is expected to decrease through the years. Other factors such as data interpretation tools, growth of supportive library preparation procedures, and technological advancements are accountable for the lucrative adoption of next generation oncology tests among researchers. Request Sample Copy of this Market Research @ https://www.millioninsights.com/industry-reports/next-generation-cancer-diagnostics- market/request-sample Major categorization for the types of cancer includes cervical, breast, lung, colorectal, and other tumor forms. The other types constitute leukemia, prostate, bladder, brain, skin, uterine, esophageal, Non-Hodgkin lymphoma, ovarian, liver, and thyroid. In 2015, as per World Health Organization lung cancer was accountable for approximately 1.7 million deaths. Moreover, breast cancer incidence is also estimated to grow thereby escalating the demand for screening and diagnostic technologies. Application Insights Growth in the number of research schemes to develop novel products and services which enable primary detection of tumor-causing mutations is expected to affect the advancement in genetic analysis over the forecast period. Biomarker tests offer greater sensitivity in screening and also demonstrate 90% accuracy levels in investigational studies which is attributive to induce progress in the coming years. Table Of Contents 1Next Generation Cancer Diagnostics Overview 2Global Next Generation Cancer Diagnostics Application Estimates & Trend Analysis 3Global Next Generation Cancer Diagnostics Size and Growth Prospects 4Global Next Generation Cancer Diagnostics Analysis by Region 5Global Next Generation Cancer Diagnostics Analysis by Type 6Global Next Generation Cancer Diagnostics Analysis by Application 7Global Next Generation Cancer Diagnostics Manufacturers Analysis

3. 8Global Next Generation Cancer Diagnostics Technology and Development Trends Browse Full Research Report @ https://www.millioninsights.com/industry-reports/next-generation-cancer-diagnostics-market Get in touch At Million Insights, we work with the aim to reach the highest levels of customer satisfaction. Our representatives strive to understand diverse client requirements and cater to the same with the most innovative and functional solutions. Contact Person: Ryan Manuel Research Support Specialist, USA Email: ryan@millioninsights.com Global Headquarters Million Insights Felton Office Plaza 6265 Highway 9 Felton, California 95018, United States Phone: 1-408-610-2300 Email: sales@millioninsights.com Asia Pacific Million Insights Office No. 302, 3rd Floor, Manikchand Galleria, Model Colony, Shivaji Nagar, Pune, MH, 411016 India Phone: 91-20-65300184